ERBB2 and breast carcinoma: At least four distinct clinically significant molecular subtypes of breast cancer are thought to exist since the seminal work of Perou, Sørlie, and associates at the start of this millennium: basal-like, HER2-enriched, luminal A, and luminal B (Perou et al., 2000; Sørlie et al., 2001).